Storage of genetic data using blockchain

LifeBank Chain is a leading clinic-stage biotechnology company seeking to improve lives through the curative potential of gene and cell therapy.

Discover

Lifebank Chain focuses on the research, development of genetics, cytology, and expands the innovative applications of genetics and cytology in clinical treatment through cutting-edge technology.

LBC Milestones

2021 Q2

Establishment of Israel Company, devoted to human genetic and cell R&D

2021 Q3

Advanced research begins to determine the market and develop blockchain infrastructure

2022 Q1

Demo testing for LBCApplication “LBC Health” v1.0 will begin

2022 Q2

Release of the LBCApplication “LBC Health” v1.1; Enrollment begins for doctors, patients, and genetic and cell laboratories in China, South Korea, Japan, and Singapore

Management Team

The team of researchers and genome experts supporting the program is based in Singapore, Canada, and China, and include two Nobel prize winners. This makes LBC the first of its kind to be supported by Nobel Prize laureates.

Randy Schekman

Sabeeha Merchant

Eric Maskin

Press Release

02/08/2025

Predictive genetic and stem cell information
The LBC committee recommends that regardless of the institutional structure of the entity
The LBC committee recommends that for a proper informed
Predictive genetic and stem cell information

Our Research and Development Partners

LifeBank Chain is constantly looking for partners and research collaborators. Contact us for more information.

UNSW Sydney University of Technology Sydney Kyocera